<DOC>
	<DOCNO>NCT01127165</DOCNO>
	<brief_summary>The purpose study confirm adjustment dosage zonisamide monotherapy child epilepsy .</brief_summary>
	<brief_title>Low High Dose Zonisamide Children Monotherapy</brief_title>
	<detailed_description />
	<mesh_term>Zonisamide</mesh_term>
	<criteria>Inclusion criterion : 1 . Pediatric patient epilepsy whose age 2~15 year old . 2 . Patients least two seizure last 6 month entry . 3 . Patients never take antiepileptic drug . 4 . Patients chance progressive disease base result magnetic resonance imaging ( MRI ) electroencephalogram ( EEG ) . 5 . Agreement guardian need . Exclusion criterion : 1 . Patients progressive central nervous system ( CNS ) disease . 2 . Patients serious disorder . 3 . Patients abnormal liver function ( serum glutamic oxaloacetic transaminase [ SGOT ] ) ( serum glutamic pyruvic transaminase [ SGPT ] ) value twice normal value . 4 . Patients abnormal renal function ( blood urea nitrogen ( BUN ) Creatinine ) value three time normal value . 5 . Hemolytic anemia .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>